The briefing
Inside Precision Medicine reports that elevated blood levels of phosphorylated tau 217 were found among older adults who later developed cognitive decline. The findings suggest p‑tau217 testing could help identify patients who may benefit from disease‑modifying therapies.
Original headline
Blood Test Foresees Decline into Alzheimer’s Disease